Zealand Pharma A/S
DelistedCIK 1674988fmd_16FE5VZGY437XCCT0FW3189405Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2021, 9 periods
Latest annual · FY2021
Millions- Total revenues
- 293
- Gross profit
- 174
- Operating income
- (1,052)
- Net income
- (1,018)
- Free cash flow
- (1,234)
Latest quarter · Q4 FY2020
Millions- Total revenues
- 63
- Gross profit
- 35
- Operating income
- (343)
- Net income
- (381)
- Free cash flow
- (273)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +97.5%
- Revenue, 5 yearsFY2016 to FY2021
- +4.9%
- Net income, 5 yearsFY2016 to FY2021
- n/m
Zealand Pharma A/S financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | DKK 292.6 million | DKK 353.3 million | -17.2% | 20-F 2022-03-25 · proof |
| Gross profit | DKK 173.8 million | DKK 262.7 million | -33.9% | 20-F 2022-03-25 · proof |
| Operating income | -DKK 1.1 billion | -DKK 792.4 million | 20-F 2022-03-25 · proof | |
| Net income | -DKK 1 billion | -DKK 846.7 million | 20-F 2022-03-25 · proof | |
| Cash from operating activities | -DKK 1.2 billion | -DKK 688.7 million | 20-F 2022-03-25 · proof | |
| Free cash flow | -DKK 1.2 billion | -DKK 713.8 million | 20-F 2022-03-25 · proof | |
| Total assets | DKK 2.1 billion | DKK 1.8 billion | +17.3% | 20-F 2022-03-25 · proof |
| Total liabilities | DKK 1.1 billion | DKK 532.6 million | +114% | 20-F 2022-03-25 · proof |
| Cash and cash equivalents | DKK 1.1 billion | DKK 960.2 million | +17.6% | 20-F 2022-03-25 · proof |
- What was Zealand Pharma A/S's revenue in fiscal 2021?
- Zealand Pharma A/S reported revenue of DKK 292.6 million for fiscal 2021 (the year ended Dec 31, 2021), against DKK 353.3 million the year before (-17.2%). Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What was Zealand Pharma A/S's gross profit in fiscal 2021?
- Zealand Pharma A/S reported gross profit of DKK 173.8 million for fiscal 2021 (the year ended Dec 31, 2021), against DKK 262.7 million the year before (-33.9%). Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What was Zealand Pharma A/S's operating income in fiscal 2021?
- Zealand Pharma A/S reported operating income of -DKK 1.1 billion for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 792.4 million the year before. Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What was Zealand Pharma A/S's net income in fiscal 2021?
- Zealand Pharma A/S reported net income of -DKK 1 billion for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 846.7 million the year before. Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What was Zealand Pharma A/S's cash from operating activities in fiscal 2021?
- Zealand Pharma A/S reported cash from operating activities of -DKK 1.2 billion for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 688.7 million the year before. Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What was Zealand Pharma A/S's free cash flow in fiscal 2021?
- Zealand Pharma A/S reported free cash flow of -DKK 1.2 billion for fiscal 2021 (the year ended Dec 31, 2021), against -DKK 713.8 million the year before. Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What are Zealand Pharma A/S's total assets?
- As of Dec 31, 2021, Zealand Pharma A/S reported total assets of DKK 2.1 billion, against DKK 1.8 billion a year earlier (+17.3%). Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What are Zealand Pharma A/S's total liabilities?
- As of Dec 31, 2021, Zealand Pharma A/S reported total liabilities of DKK 1.1 billion, against DKK 532.6 million a year earlier (+114%). Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
- What are Zealand Pharma A/S's cash and cash equivalents?
- As of Dec 31, 2021, Zealand Pharma A/S reported cash and cash equivalents of DKK 1.1 billion, against DKK 960.2 million a year earlier (+17.6%). Source: the 20-F filed with the SEC on Mar 25, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1674988&period_type=annual&limit=5"Information only, not investment advice.